Healthcare Services

Cell Transfection Market Developments and Growth Opportunities Across 2026–2030

March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Cell Transfection Market In 2026 And What Value Is Projected For 2030?

The cell transfection market size has demonstrated significant growth over recent years. It is anticipated to expand from $1.42 billion in 2025 to $1.55 billion in 2026, driven by a compound annual growth rate (CAGR) of 9.2%. This historical expansion can be attributed to several factors including the broadening of molecular biology research, the increased utilization of gene expression studies, the rise in recombinant protein production, the growing adoption of in vitro genetic manipulation, and the availability of a variety of transfection methods.

The cell transfection market is anticipated to experience robust expansion over the coming years. This market is projected to reach $2.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9%. This predicted growth stems from factors such as the accelerated development of gene and cell therapies, increased investments in genetic engineering research, a rising demand for high-throughput screening assays, the expansion of personalized medicine research, and the increasing adoption of non-viral delivery technologies. Key trends anticipated during this period encompass the greater adoption of high-efficiency transfection reagents, an increase in the use of viral vector-based transfection, a growing need for scalable transfection methods, the expansion of automated transfection platforms, and a heightened emphasis on transfection reproducibility.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19361&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Cell Transfection Market?

The increasing incidence of infectious diseases is projected to drive the future growth of the cell transfection market. Infectious diseases are illnesses stemming from germs that disseminate from person to person or via contaminated sources. Inadequate public health infrastructure, along with vaccine hesitancy and misinformation, has facilitated the spread and evolution of pathogens. Cell transfection serves as a potent tool for infectious diseases, enabling scientists to introduce genes into cells to investigate how infections affect them and to evaluate new treatments. For instance, in October 2024, according to the World Health Organization, a Switzerland-based international public health organization, roughly 8.2 million people were newly diagnosed with tuberculosis in 2023, an increase from about 7.5 million in 2022, identifying tuberculosis as the leading infectious disease killer. Consequently, the rise in infectious disease cases propels the cell transfection market.

What Are The Key Segments Of The Cell Transfection Market?

The cell transfection market covered in this report is segmented –

1) By Method: Electroporation, Lipofection, Calcium Phosphate, Viral Transfection, Other Methods

2) By Application: Biomedical Research, Therapeutic Delivery, Protein Production

3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Electroporation: Square Wave Electroporation, Pulsed Electric Field Electroporation, Multielectrode Array Electroporation

2) By Lipofection: Cationic Lipid-Based Transfection, Lipid Nanoparticle-Based Transfection, Liposomal Transfection

3) By Calcium Phosphate: Calcium Phosphate Co-precipitation, Modified Calcium Phosphate Methods

4) By Viral Transfection: Lentiviral Transduction, Adenoviral Transduction, AAV (Adeno-Associated Virus) Transduction

5) By Other Methods: Microinjection, Nanoparticle-Mediated Transfection, Sonoporation, Magnetofection

What Trends Are Projected To Affect The Cell Transfection Market?

Major companies operating in the cell transfection market are actively integrating innovations into their transfection systems to enable precise control over gene expression. A transfection system is a technique or technology specifically designed to introduce foreign nucleic acids into cells, serving purposes like studying gene function, producing proteins, or altering gene expression. For instance, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, launched the Cellpore transfection system, a novel tool engineered to enhance cell engineering research. This system leverages advanced microfluidic technology to facilitate the intracellular delivery of various macromolecules into cells, thereby addressing limitations associated with traditional transfection methods. It possesses the capability to transfect up to 10 million cells per second, rendering it suitable for large-scale applications. Moreover, the system demonstrates compatibility with diverse cell types, including T cells and hematopoietic stem cells, and can effectively deliver various cargoes such as small molecules, Ribonucleic Acid (RNA), proteins, and antibodies.

Who Are The Leading Companies Operating In The Cell Transfection Market?

Major companies operating in the cell transfection market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Stemcell Technologies Inc., GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Molecular Devices LLC, New England Biolabs Inc., CureVac SE, OriGene Technologies Inc., Tocris Bioscience, Vector Biolabs, Mirus Bio LLC, Addgene Inc., Altogen Biosystems, Cell Biolabs Inc., Cellecta Inc., ExCell Bio Inc., GeneCopoeia Inc.

Read the full cell transfection market report here:

https://www.thebusinessresearchcompany.com/report/cell-transfection-global-market-report

What Are The Leading Geographic Regions In The Cell Transfection Market?

North America was the largest region in the cell transfection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell transfection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Transfection Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19361&type=smp

Browse Through More Reports Similar to the Global Cell Transfection Market 2026, By The Business Research Company

Cells Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Therapy Human Raw Materials Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-therapy-human-raw-materials-global-market-report

Stem Cells Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795